APWM
AMED

Argonautica Private Wealth Management’s Amedisys AMED Stock Holding History

Argonautica Private Wealth Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,714
Closed -$250K – 198
2024
Q1 		$250K Sell
2,714
-293
-10% -$27.5K 0.09% 180
2023
Q4 		$286K Buy
3,007
+4
+0.1% +$374 0.12% 157
2023
Q3 		$280K Buy
3,003
+172
+6% +$15.9K 0.13% 154
2023
Q2 		$259K Buy
+2,831
New +$232K 0.12% 165

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Argonautica Private Wealth Management's AMED Position: Q2 2024 in Review

Argonautica Private Wealth Management sold out of Amedisys (AMED) in Q2 2024, closing a stake of 2,714 shares — an estimated $250K sold.

Argonautica Private Wealth Management first reported a position in AMED in Q2 2023 and held it in 4 quarters. The position peaked at $286K in Q4 2023. 288 funds tracked by Wall St. Rank hold AMED as of Q2 2024.

  • Argonautica Private Wealth Management reported no remaining Amedisys position as of Q2 2024 after selling out during the quarter.
  • Argonautica Private Wealth Management sold 2,714 Amedisys shares in Q2 2024, an estimated $250K.
  • Argonautica Private Wealth Management first reported a position in Amedisys in Q2 2023 and held it in 4 quarters.
  • Argonautica Private Wealth Management's Amedisys position peaked at $286K in Q4 2023.
  • 288 funds tracked by Wall St. Rank held Amedisys as of Q2 2024.

Based on Argonautica Private Wealth Management's 13F filing for Q2 2024, filed 26 Jul 2024.